Work

Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression

Year: 2025

Type: article

Source: The American Journal of Drug and Alcohol Abuse

DOI: 10.1080/00952990.2025.2541212

Authors: Peter Manza, Annabelle M. Belcher, Heather Fitzsimons, Max Spaderna, Aaron D. Greenblatt, Hannah C. Smith, Meghan Derenoncourt, Donald Gann, Umer Farooq, Mark D. Kvarta, Bethany A. DiPaula, Sarah Merritt, Ivana Mitic, Carlos A. Zarate, Todd D. Gould, Eric Weintraub, Sarah M. Kattakuzhy

Institutions: University of Maryland, Baltimore, National Institutes of Health, National Institutes of Health Clinical Center, National Institute of Mental Health, National Institute of Mental Health, University of Maryland, College Park, LifeStream, VA Maryland Health Care System

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413428353

FWCI: 0.849

Cites: 56

Cited by: 1

Related to: 10